A number of microRNAs (miRNAs), including miR-200 family, are aberrantly expressed in endometriosis and endometrial cancer. Here we assessed the expression and functional aspects of miR-200c in endometrial tissues (N = 52) from normal endometrial biopsies (N = 15), endometrial tissues including those exposed to hormonal therapies (N = 20), and grade I-III endometrial cancer (N = 17). miR-200c expression was elevated in normal endometrial biopsies from mid- and late-luteal phase, and in endometrial tumors as compared to endometrial tissues from peri- and postmenopausal period (P < .05) and its pattern of temporal expression displayed an inverse relationship with the expression of ZEBs. The expression of E-cadherin (CDH1) varied, but expressed at low levels, specifically in endometrial tissues and endometrial tumors. The endometrial expression of ZEBs and CDH1 in patients who were exposed to Depo-Provera and gonadotropin-releasing hormone agonist GnRHa displayed a trend toward lower expression as compared to proliferative phase; however, treatment of Ishikawa cells with 17β-estradiol, progesterone, and medroxy progesterone acetate had modest effects on the expression of miR-200c and ZEBs without affecting CDH1 expression. Gain of function of miR-200c in Ishikawa cells repressed ZEBs, as well as VEGFA, FLT1, IKKβ, and KLF9 expression at transcriptional and translational levels through direct interaction with their respective 3′untranslated regions and increased the rate of their proliferation. These results indicated that endometrial miR-200c expression undergoes dynamic changes during transition from normal into cancerous states; possibly influenced by hormonal milieu and by targeting the expression of specific genes with key regulatory functions in cellular transformation, inflammation, and angiogenesis may influence these events during normal and disease progression.
DjuranovicSNahviAGreenR. A parsimonious model for gene regulation by miRNAs. Science. 2011;331(6017):550–553.
2.
DykxhoornDM. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res. 2010;70(16):6401–6406.
3.
FabianMRSonenbergNFilipowiczW. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–379.
4.
SchickelRBoyerinasBParkSMPeterME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene. 2008;27(45):5959–5974.
5.
BrabletzSBrabletzT. The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?EMBO Rep. 2010;11(9):670–677.
6.
SmallEMOlsonEN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011;469(7330):336–342.
7.
GonzalezGBehringerRR. Dicer is required for female reproductive tract development and fertility in the mouse. Mol Reprod Dev. 2009;76(7):678–688.
8.
HongXLuenseLJMcGinnisLKNothnickWBChristensonLK. Dicer1 is essential for female fertility and normal development of the female reproductive system. Endocrinology. 2008;149(12):6207–6212.
9.
NagarajaAKAndreu-VieyraCFrancoHL. Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol. 2008;22(10):2336–2352.
10.
BorenTXiongYHakamA. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol. 2008;110(2):206–215.
11.
CohnDEFabbriMValeriN. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol. 2010;202(6):656–658.
12.
HawkinsSMBucholdGMMatzukMM. Minireview: the roles of small RNA pathways in reproductive medicine. Mol Endocrinol. 2011;25(8):1257–1279.
13.
HawkinsSMCreightonCJHanDY. Functional MicroRNA Involved in Endometriosis. Mol Endocrinol. 2011;25(5):821–832.
14.
MyattSSWangJMonteiroLJ. Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res. 2010;70(1):367–377.
15.
Ohlsson TeagueEMVan der HoekKHVan der HoekMB. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol. 2009;23(2):265–275.
16.
PanQLuoXToloubeydokhtiTCheginiN. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod. 2007;13(11):797–806.
17.
RamonLABraza-BoilsAGilabert-EstellesJ. MicroRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod. 2011;26(5):1082–1090.
18.
CastillaMAMoreno-BuenoGRomero-PerezL. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol. 2011;223(1):72–80.
19.
CochraneDRHoweENSpoelstraNSRicherJK. Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol. 2010;2010:821717.
20.
FilighedduNGregnaninIPorporatoPE. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol. 2010;2010:369549.
21.
KuokkanenSChenBOjalvoLBenardLSantoroNPollardJW. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod. 2010;82(4):791–801.
22.
LeeJWParkYAChoiJJ. The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol. 2011;120(1):56–62.
23.
DavalosVEstellerM. Opening the treasure chest of miR-200 s family members. Cell Cycle. 2009;8(14):2141–2142.
24.
ChanYCKhannaSRoyS, Sen CK. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 2011;286(3):2047–2056.
25.
IliopoulosDLindahl-AllenMPolytarchouCHirschHATsichlisPNStruhlK. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell. 2010;39(5):761–772.
26.
KongDLiYWangZ. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells. 2009;27(8):1712–1721.
27.
KorpalMEllBJBuffaFM. Direct targeting of Sec23a by miR-200 s influences cancer cell secretome and promotes metastatic colonization. Nat Med. 2011;17(9):1101–1108.
28.
RoybalJDZangY, Ahn YH, et al. miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res. 2011;9(1):25–35.
29.
UhlmannSZhangJDSchwagerA. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010;29(30):4297–4306.
30.
WangBKohPWinbanksC. miR-200a prevents renal fibrogenesis through repression of TGF-beta2 expression. Diabetes. 2011;60(1):280–287.
31.
RenthalNEChenCCWilliamsKCGerardRDPrange-KielJMendelsonCR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A. 2010;107(48):20828–20833.
32.
DahiyaNSherman-BaustCAWangTL. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One. 2008;3(6):e2436.
33.
InomataMTagawaHGuoYMKameokaYTakahashiNSawadaK. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood. 2009;113(2):396–402.
34.
ChenRAlveroABSilasiDA. Regulation of IKK[beta] by miR-199a affects NF-[kappa]B activity in ovarian cancer cells. Oncogene. 2008;27(34):4712–4723.
35.
SpoelstraNSManningNGHigashiY. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 2006;66(7):3893–3902.
36.
SinghMSpoelstraNSJeanA. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol. 2008;21(7):912–923.
37.
SnowdonJZhangXChildsTTronVAFeilotterH. The microRNA-200 family is upregulated in endometrial carcinoma. PLoS One. 2011;6(8):e22828.
38.
SpoelstraNSManningNGHigashiY. The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 2006;66(7):3893–3902.
39.
YoshimotoNToyamaTTakahashiS. Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer. Breast Cancer Res Treat. 2011;130(1):331–339.
40.
BendoraiteAKnoufECGargKS. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol. 2010;116(1):117–125.
41.
BrabletzSBajdakKMeidhofS. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J. 2011;30(4):770–782.
42.
DykxhoornDMWuY, Xie H, et al. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One. 2009;4(9):e7181.
43.
GregoryPABertAGPatersonEL. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10(5):593–601.
44.
XiaHNgSS, Jiang S, et al. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem Biophys Res Commun. 2010;391(1):535–541.
45.
KalluriRWeinbergRA. The basics of epithelial-mesenchymal transition. J Clin Invest2009;119(6):1420–1428.
46.
ThieryJPAcloqueHHuangRYNietoMA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871–890.
47.
VandewalleCComijnJDeCB. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005;33(20):6566–6578.
48.
ChenSULeeHChangDY. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta. Endocrinology. 2008;149(11):5888–5896.
49.
GraesslinOCortezAFauvetRLorenzatoMBirembautPDaraiE. Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol. 2006;17(4):637–645.
50.
HannanNJPaivaPMeehanKLRombautsLJGardnerDKSalamonsenLA. Analysis of fertility-related soluble mediators in human uterine fluid identifies VEGF as a key regulator of embryo implantation. Endocrinology. 2011;152(12):4948–4956.
51.
HuangFLiuQWangHZouY. Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(5):409–418.
52.
KingAECritchleyHOKellyRW. The NF-kappaB pathway in human endometrium and first trimester decidua. Mol Hum Reprod. 2001;7(2):175–183.
53.
MaybinJAHiraniNJabbourHNCritchleyHO. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am J Pathol. 2011;178(3):1245–1256.
54.
MaybinJAHiraniNBrownPJabbourHNCritchleyHO. The regulation of vascular endothelial growth factor by hypoxia and prostaglandin Falpha during human endometrial repair. J Clin Endocrinol Metab. 2011;96(8):2475–2483.
55.
OkadaHOkamotoRTsuzukiTTsujiSYasudaKKanzakiH. Progestins inhibit estradiol-induced vascular endothelial growth factor and stromal cell-derived factor 1 in human endometrial stromal cells. Fertil Steril. 2011;96(3):786–791.
56.
SimmenRCPabonaJMVelardeMCSimmonsCRahalOSimmenFA. The emerging role of Kruppel-like factors in endocrine-responsive cancers of female reproductive tissues. J Endocrinol. 2010;204(3):223–231.
57.
TaylorRNYuJTorresPB. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009;16(2):140–146.
58.
UlukusMUlukusECTavmergen GokerENTavmergenEZhengWAriciA. Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis. Fertil Steril. 2009;91(3):687–693.
59.
DaiLGuLDiW. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKK{beta}/NF-kB pathway and reduced interleukin-8 expression. Mol Hum Reprod. 2011;18(3):136–145.
60.
JulienSPuigICarettiE. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene. 2007;26(53):7445–7456.
61.
DuHSarnoJTaylorHS. HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium. Biol Reprod. 2010;83(2):205–211.
62.
SimmonsCDPabonaJMHeardME. Kruppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen. Biol Reprod. 2011;85(2):378–385.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
